Wells Fargo & Company Guardant Health, Inc. Call Options Transaction History

Wells Fargo & Company

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 13, 2023	BUY	$25.44 - $59.78 $508,800 - $1.2 Million	20,000 New	20,000 $544,000
Q1 2022 May 16, 2022	BUY	$48.25 - $100.49 $236,425 - $492,401	4,900 Added 49.0%	14,900 $987,000
Q1 2021 May 13, 2021	SELL	$127.04 - $179.1 $952,800 - $1.34 Million	-7,500 Reduced 42.86%	10,000 $1.53 Million
Q4 2020 Feb 09, 2021	SELL	$99.96 - $135.93 $1.5 Million - $2.04 Million	-15,000 Reduced 46.15%	17,500 $507,000
Q3 2020 Nov 05, 2020	BUY	$80.32 - $111.8 $2.61 Million - $3.63 Million	32,500 New	32,500 $615,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.23B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.